Mechanism of action of antimycobacterial activity of the new benzoxazinorifamycin KRM-1648.
The mechanism of antimicrobial activity of KRM-1648 (KRM), a new rifamycin derivative with potent antimycobacterial activity, was studied. Both KRM and rifampin (RMP) inhibited RNA polymerases from Escherichia coli and Mycobacterium avium at low concentrations: the 50% inhibitory concentrations (IC5...
Kaydedildi:
| Yayımlandı: | Antimicrob Agents Chemother |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Microbiology (ASM)
1995
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162768/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7492091/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.7.1489 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|